Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodoros Agorastos

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Annals of the New York Academy of Sciences|September 16, 2010
Can HPV testing replace the pap smear?Theodoros Agorastos, Alexandros Sotiriadis, Konstantinos Chatzigeorgiou
Archives of Gynecology and Obstetrics|August 21, 2013
Letter to the editor referring to the manuscript entitled: "Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine" reported by Sotiriadis et al. (Arch Gynecol Obstet. 2012 Jun;285(6):1719-24)Kimon Chatzistamatiou, Alexandros Sotiriadis, Theodoros Agorastos
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 6, 2010
Effect of type-specific human papillomavirus incidence on screening performance and costTheodoros Agorastos, Alexandros Sotiriadis, Christos J Emmanouilides
Archives of Gynecology and Obstetrics|February 20, 2003
Atypical endometrial hyperplasia in an 18-year-old womanTheodoros Agorastos, Violetta Vaitsi, Andromache Vakiani, et al.
Archives of Gynecology and Obstetrics|January 17, 2012
Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccineAlexandros Sotiriadis, Themistoklis Dagklis, Vaia Siamanta, et al.
Gynecologic Oncology|April 30, 2016
Comparison of cytology, HPV DNA testing and HPV 16/18 genotyping alone or combined targeting to the more balanced methodology for cervical cancer screeningKimon Chatzistamatiou, Theodoros Moysiadis, Viktoria Moschaki, et al.
Archives of Gynecology and Obstetrics|December 7, 2013
Response to: Media effect-letter to the editor about the manuscript titled Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccineAlexandros Sotiriadis, Themistoklis Dagklis, Vaia Siamanta, et al.
Journal of Clinical Ultrasound : JCU|January 31, 2012
Thalamic volume measurement in normal fetuses using three-dimensional sonographyAlexandros Sotiriadis, Ioannis Dimitrakopoulos, Makarios Eleftheriades, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 6, 2010
Cervical, uterine corpus, and ovarian cancer mortality in Greece during 1980 to 2005: a trend analysisEvangelia Pavlidou, Menelaos Zafrakas, Nikolaos Papadakis, et al.
Plos One|December 13, 2019
Economic evaluation of HPV DNA test as primary screening method for cervical cancer: A health policy discussion in GreeceAnastasios Skroumpelos, Theodoros Agorastos, Theodoros Constantinidis, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Annals of the New York Academy of Sciences|September 16, 2010
Can HPV testing replace the pap smear?Theodoros Agorastos, Alexandros Sotiriadis, Konstantinos Chatzigeorgiou
Archives of Gynecology and Obstetrics|August 21, 2013
Letter to the editor referring to the manuscript entitled: "Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine" reported by Sotiriadis et al. (Arch Gynecol Obstet. 2012 Jun;285(6):1719-24)Kimon Chatzistamatiou, Alexandros Sotiriadis, Theodoros Agorastos
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 6, 2010
Effect of type-specific human papillomavirus incidence on screening performance and costTheodoros Agorastos, Alexandros Sotiriadis, Christos J Emmanouilides
Archives of Gynecology and Obstetrics|February 20, 2003
Atypical endometrial hyperplasia in an 18-year-old womanTheodoros Agorastos, Violetta Vaitsi, Andromache Vakiani, et al.
Archives of Gynecology and Obstetrics|January 17, 2012
Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccineAlexandros Sotiriadis, Themistoklis Dagklis, Vaia Siamanta, et al.
Gynecologic Oncology|April 30, 2016
Comparison of cytology, HPV DNA testing and HPV 16/18 genotyping alone or combined targeting to the more balanced methodology for cervical cancer screeningKimon Chatzistamatiou, Theodoros Moysiadis, Viktoria Moschaki, et al.
Archives of Gynecology and Obstetrics|December 7, 2013
Response to: Media effect-letter to the editor about the manuscript titled Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccineAlexandros Sotiriadis, Themistoklis Dagklis, Vaia Siamanta, et al.
Journal of Clinical Ultrasound : JCU|January 31, 2012
Thalamic volume measurement in normal fetuses using three-dimensional sonographyAlexandros Sotiriadis, Ioannis Dimitrakopoulos, Makarios Eleftheriades, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 6, 2010
Cervical, uterine corpus, and ovarian cancer mortality in Greece during 1980 to 2005: a trend analysisEvangelia Pavlidou, Menelaos Zafrakas, Nikolaos Papadakis, et al.
Plos One|December 13, 2019
Economic evaluation of HPV DNA test as primary screening method for cervical cancer: A health policy discussion in GreeceAnastasios Skroumpelos, Theodoros Agorastos, Theodoros Constantinidis, et al.
Pageof 6